Target intelligence / Profile preview

Snail family transcriptional repressor 1 (SNAI1)

Target
SNAI1
Molecular classification
Transcription factor, Zinc finger protein
01

Overview

Snail family transcriptional repressor 1 (SNAI1), also known simply as Snail, is a **zinc-finger transcription factor** encoded by the human SNAI1 gene. It is a master regulator of epithelial–mesenchymal transition (EMT), a process by which epithelial cells acquire mesenchymal, migratory, and invasive properties. SNAI1 functions by binding to E-box sequences in DNA and repressing the expression of genes such as E-cadherin, leading to decreased cell–cell adhesion and increased cell migration. Its activity is essential in embryonic development for mesoderm formation and neural crest migration, but also plays a key pathological role by promoting tumor progression, metastasis, resistance to apoptosis, and cancer recurrence through EMT induction. Beyond EMT, SNAI1 also influences cell survival, immune regulation, stem cell maintenance, and is tightly regulated by various signaling pathways including WNT and FGF. Snail expression and activity are considered biomarkers for poor prognosis and metastatic potential in various cancers[1][2][4][6][8].

Other names
SnailZinc finger protein SNAI1SNAIL1Snail1
02

Mechanism of action

(for candidate drugs/inhibitors) Transcriptional derepression of E-cadherin, inhibition of EMT-associated transcriptional networks, modulation of cell survival pathways.

03

Biological functions

Regulation of epithelial–mesenchymal transition (EMT)Transcriptional repressionCell survivalCell polarityCell migrationStem cell biologyApoptosisImmune regulation
04

Disease associations

Cancer (notably in tumor progression and metastasis)Recurrence of breast cancerOther (implicated in developmental disorders)
05

Safety considerations

Potential effects on normal developmental EMT and cell migrationpossible effects on wound healingstem cell regulationimmune homeostasis if therapeutically inhibited[2][4].
06

Interacting drugs

None established as approved therapeutics; preclinical attempts to target SNAI1 or its pathway in cancer exist, but no specific drugs on market directly target SNAI1 as of now[1][2][4][8].
07

Biomarkers

Loss of E-cadherin expression (indicative of EMT activity)nuclear localization of Snail in tumors (diagnostic/prognostic marker for malignancy/metastatic potential)[8].

Beyond the preview

Go deeper on Snail family transcriptional repressor 1 (SNAI1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Snail family transcriptional repressor 1 (SNAI1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call